Specificity and robustness of the mammalian MAPK-IEG network.

The mitogen-activated protein kinase cascade is a conserved signal transduction pathway found in organisms of complexity spanning from yeast to humans. In many mammalian tissue types, this pathway can correctly transduce signals from different extracellular messengers, leading to specific and often mutually exclusive cellular responses. The transduced signal is tuned by a complicated set of positive and negative feedback control mechanisms and fed into a downstream gene expression network. This network, based on the immediate early gene system, has two possible, mutually exclusive outcomes. Using a mathematical model, we study how different stimuli lead to different temporal signal structure. Further, we investigate how each of the feedback controls contributes to the overall specificity of the gene expression output, and hypothesize that the complicated nature of the mammalian mitogen-activated protein kinase pathway results in a system able to robustly identify and transduce the proper signal without investing in two completely separate signal cascades. Finally, we quantify the role of the RKIP protein in shaping the signal, and propose a novel mechanism of its involvement in cancer metastasis.

[1]  Muffy Calder,et al.  When kinases meet mathematics: the systems biology of MAPK signalling , 2005, FEBS letters.

[2]  Pierre Baldi,et al.  The fixed-size Luria-Delbruck model with a nonzero death rate. , 2007, Mathematical biosciences.

[3]  Rey-Huei Chen,et al.  Molecular interpretation of ERK signal duration by immediate early gene products , 2002, Nature Cell Biology.

[4]  W P Angerer,et al.  An explicit representation of the Luria–Delbrück distribution , 2001, Journal of mathematical biology.

[5]  Stephen Gilmore,et al.  Modelling the Influence of RKIP on the ERK Signalling Pathway Using the Stochastic Process Algebra PEPA , 2006, Trans. Comp. Sys. Biology.

[6]  Xiufen Zou,et al.  A theoretical framework for specificity in cell signaling , 2005, Molecular systems biology.

[7]  W. Kolch.  Coordinating ERK/MAPK signalling through scaffolds and inhibitors , 2005, Nature Reviews Molecular Cell Biology.

[8]  O. Rath,et al.  The RKIP (Raf-1 Kinase Inhibitor Protein) conserved pocket binds to the phosphorylated N-region of Raf-1 and inhibits the Raf-1-mediated activated phosphorylation of MEK. , 2008, Cellular Signalling.

[9]  J. Jass,et al.  Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer. , 2007, American journal of clinical pathology.

[10]  W. Kolch,et al.  Conferring specificity on the ubiquitous Raf/MEK signalling pathway , 2004, British Journal of Cancer.

[11]  Kevin T. Mc Henry,et al.  Raf kinase inhibitor protein positively regulates cell–substratum adhesion while negatively regulating cell–cell adhesion , 2008, Journal of cellular biochemistry.

[12]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[13]  Xiufen Zou,et al.  Mathematical models of specificity in cell signaling. , 2007, Biophysical journal.

[14]  C. Der,et al.  Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer , 2007, Oncogene.

[15]  K. Pumiglia,et al.  Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Kim,et al.  A hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK Pathways , 2007, Oncogene.

[17]  Oliver E. Sturm,et al.  Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway. , 2005, The Biochemical journal.

[18]  Shinya Kuroda,et al.  Prediction and validation of the distinct dynamics of transient and sustained ERK activation , 2005, Nature Cell Biology.

[19]  O. Rath,et al.  MAP kinase signalling pathways in cancer , 2007, Oncogene.

[20]  P. Jansen,et al.  Tyrosine-specific MAPK phosphatases and the control of ERK signaling in PC12 cells , 2006, Journal of molecular signaling.

[21]  M. Ueda,et al.  Stochastic signal processing and transduction in chemotactic response of eukaryotic cells. , 2007, Biophysical journal.

[22]  I. Amelio,et al.  Shp2 in PC12 cells: NGF versus EGF signalling. , 2007, Cellular signalling.

[23]  W. Cong,et al.  Genomic instability in hepatocellular carcinoma revealed by using the random amplified polymorphic DNA method , 2004, Journal of Cancer Research and Clinical Oncology.

[24]  Timothy C Elston,et al.  Mathematical and computational analysis of adaptation via feedback inhibition in signal transduction pathways. , 2007, Biophysical journal.

[25]  H. Lee,et al.  Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. , 2006, Gastroenterology.

[26]  Peng Sun,et al.  Sustained activation of M‐Ras induced by nerve growth factor is essential for neuronal differentiation of PC12 cells , 2006, Genes to cells : devoted to molecular & cellular mechanisms.

[27]  O. Rath,et al.  MAP kinase signaling pathways in cancer. Oncogene , 2007 .

[28]  T. Elston,et al.  Kinetic insulation as an effective mechanism for achieving pathway specificity in intracellular signaling networks , 2007, Proceedings of the National Academy of Sciences.

[29]  Jeremy S Edwards,et al.  MAPK cascade possesses decoupled controllability of signal amplification and duration. , 2004, Biophysical journal.

[30]  Jason M Haugh,et al.  A unified model for signal transduction reactions in cellular membranes. , 2002, Biophysical journal.

[31]  P. Bastiaens,et al.  Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate , 2007, Nature Cell Biology.

[32]  Y. Mitsumoto,et al.  Centrosome aberration accompanied with p53 mutation can induce genetic instability in hepatocellular carcinoma , 2004, Modern Pathology.

[33]  W. Kolch,et al.  Raf kinase inhibitor protein regulation of raf and MAPK signaling. , 2006, Methods in enzymology.

[34]  W. Kolch,et al.  Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  W. Kolch,et al.  Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability , 2008, Journal of Clinical Pathology.

[36]  Young Sook Yoo,et al.  Kinetic analysis of the MAPK and PI3K/Akt signaling pathways. , 2008, Molecules and cells.

[37]  E. Gilles,et al.  Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors , 2002, Nature Biotechnology.

[38]  T. Sladek,et al.  Mediation of Nerve Growth Factor-driven Cell Cycle Arrest in PC12 Cells by p53 , 2000, The Journal of Biological Chemistry.

[39]  H. Bismuth,et al.  Microsatellite instability in European hepatocellular carcinoma , 1999, Oncogene.

[40]  Sunwon Park,et al.  Colored Petri net modeling and simulation of signal transduction pathways. , 2006, Metabolic engineering.

[41]  D. Welch.  Do we need to redefine a cancer metastasis and staging definitions? , 2006, Breast disease.

[42]  Xiufen Zou,et al.  Modeling specificity in the yeast MAPK signaling networks. , 2008, Journal of theoretical biology.